PharmacoEconomics & Outcomes News 398 - 8 Feb 2003

■ The US FDA has issued a written warning toPurdue Pharma requesting it to immediately ceasedistributing two misleading advertisements related tothe opioid analgesic oxycodone [‘OxyContin’]. Theadvertisements, which appeared in JAMA, promote‘OxyContin’ for uses that have not been proveneffective and omit important safety information,minimising the serious potential risks associated withthe drugs’ use, says the FDA.FDA warns over OxyContin ads. Pharma Times : [1 page], 27 Jan 2003.Available from: URL: http://www.ptwebcast.com 800925199

1

PharmacoEconomics & Outcomes News 8 Feb 2003 No. 3981173-5503/10/0398-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved